相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions
Claudia Wrzos et al.
ACTA NEUROPATHOLOGICA (2014)
Unique neuromyelitis optica pathology produced in na⟨ve rats by intracerebral administration of NMO-IgG
Nithi Asavapanumas et al.
ACTA NEUROPATHOLOGICA (2014)
A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica
Anand Iyer et al.
AUTOIMMUNITY (2014)
The mechanisms of action of plasma exchange
Hollie M. Reeves et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica
Julien Ratelade et al.
EXPERIMENTAL NEUROLOGY (2014)
Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G
Nithi Asavapanumas et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Corinna Trebst et al.
JOURNAL OF NEUROLOGY (2014)
Catastrophic brain relapse in seronegative NMO after a single dose of natalizumab
Joanna Kitley et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
Manabu Araki et al.
Modern Rheumatology (2014)
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
Liene Elsone et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The two faces of neuromyelitis optica
Brian G. Weinshenker et al.
NEUROLOGY (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Meningococcal disease and the complement system
Lisa A. Lewis et al.
VIRULENCE (2014)
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Joanna Kitley et al.
JAMA NEUROLOGY (2014)
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica Multicenter Study of Treatment Efficacy
Maureen A. Mealy et al.
JAMA NEUROLOGY (2014)
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
Samira Saadoun et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica
Puay-Wah Phuan et al.
ACTA NEUROPATHOLOGICA (2013)
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2013)
Enzymatic Deglycosylation Converts Pathogenic Neuromyelitis Optica Anti-Aquaporin-4 Immunoglobulin G into Therapeutic Antibody
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2013)
The role of Fc receptors and complement in autoimmunity
Sidonia Mihai et al.
AUTOIMMUNITY REVIEWS (2013)
Discovery of Peptoid Ligands for Anti-Aquaporin 4 Antibodies
Bindu L. Raveendra et al.
CHEMISTRY & BIOLOGY (2013)
Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks
Akiyuki Uzawa et al.
CLINICA CHIMICA ACTA (2013)
Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity
Robert C. Axtell et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Efficacy of Intravenous Cyclophosphamide Therapy for Neuromyelitis Optica Spectrum Disorder
Hiroaki Yaguchi et al.
INTERNAL MEDICINE (2013)
The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients
Ulisses C. Linhares et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica
Hua Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death
Samira Saadoun et al.
JOURNAL OF IMMUNOLOGY (2013)
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica
Takashi Kageyama et al.
JOURNAL OF NEUROLOGY (2013)
Neuromyelitis optica and pregnancy
Yara Dadalti Fragoso et al.
JOURNAL OF NEUROLOGY (2013)
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
Anu Jacob et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Joanna Kitley et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Sean J. Pittock et al.
LANCET NEUROLOGY (2013)
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica
K. Rostasy et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum
M. Ringelstein et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
The spectrum of MOG autoantibody-associated demyelinating diseases
Markus Reindl et al.
NATURE REVIEWS NEUROLOGY (2013)
Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link
S. Jarius et al.
MEDICAL HYPOTHESES (2013)
The effect of intravenous immunoglobulin on neuromyelitis optica
M. J. Magraner et al.
NEUROLOGIA (2013)
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica
Norio Chihara et al.
PLOS ONE (2013)
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica Implication for Cellular Immune Responses
Bernd C. Kieseier et al.
JAMA NEUROLOGY (2013)
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy
Ilya Ayzenberg et al.
JAMA NEUROLOGY (2013)
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies
Joanna Kitley et al.
JAMA NEUROLOGY (2013)
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder
Su-Hyun Kim et al.
JAMA NEUROLOGY (2013)
T cell-activation in neuromyelitis optica lesions plays a role in their formation
Maria Pohl et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an IgG-Selective Proteinase
Lukmanee Tradtrantip et al.
MOLECULAR PHARMACOLOGY (2013)
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Julien Ratelade et al.
ACTA NEUROPATHOLOGICA (2012)
Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Lukmanee Tradtrantip et al.
ANNALS OF NEUROLOGY (2012)
Neutrophil Protease Inhibition Reduces Neuromyelitis Optica-Immunoglobulin G-Induced Damage in Mouse Brain
Samira Saadoun et al.
ANNALS OF NEUROLOGY (2012)
Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
Michel Varrin-Doyer et al.
ANNALS OF NEUROLOGY (2012)
Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica: Evaluation of 7 Patients
Denis B. Bichuetti et al.
ARCHIVES OF NEUROLOGY (2012)
Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica
Ingo Kleiter et al.
ARCHIVES OF NEUROLOGY (2012)
Treatment of Optic Neuritis by Plasma Exchange (Add-On) in Neuromyelitis Optica
Harold Merle et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
Joanna Kitley et al.
BRAIN (2012)
Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica
Lukmanee Tradtrantip et al.
FASEB JOURNAL (2012)
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly
Andrea Rossi et al.
GLIA (2012)
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
Puay-Wah Phuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Small-molecule Screen Yields Idiotype-specific Blockers of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4
Puay-Wah Phuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Spectrum of Neuromyelitis Optica (NMO) in Childhood
J. M. Tillema et al.
JOURNAL OF CHILD NEUROLOGY (2012)
Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network
Nathalie Muls et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Sera from neuromyelitis optica patients disrupt the blood-brain barrier
Fumitaka Shimizu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
CD19 as an attractive target for antibody-based therapy
Ohad Hammer
MABS (2012)
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy
M. H. Barnett et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
Ju-Hong Min et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence
Anu Jacob et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Su-Hyun Kim et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success
Benjamin M. Greenberg et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica
Honghao Wang et al.
NEUROIMMUNOMODULATION (2012)
Influence of pregnancy on neuromyelitis optica spectrum disorder
W. Kim et al.
NEUROLOGY (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions
Samira Saadoun et al.
NEUROREPORT (2012)
Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Erwin W. Gelfand
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
Shannon R. Hinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Current and Future Immunomodulation Strategies to Restore Tolerance in Autoimmune Diseases
Jeffrey A. Bluestone et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Treatment of neuromyelitis optica: Review and recommendations
Dorlan J. Kimbrough et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2012)
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
Hua Zhang et al.
ANNALS OF NEUROLOGY (2011)
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus
Gabor G. Illei et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
Su-Hyun Kim et al.
ARCHIVES OF NEUROLOGY (2011)
Efficacy and Safety of Mitoxantrone in Patients With Highly Relapsing Neuromyelitis Optica
Su-Hyun Kim et al.
ARCHIVES OF NEUROLOGY (2011)
Eosinophils: multifaceted biological properties and roles in health and disease
Hirohito Kita
IMMUNOLOGICAL REVIEWS (2011)
Evidence against Cellular Internalization in Vivo of NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica
Julien Ratelade et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1/M23 Isoforms and Orthogonal Arrays
Jonathan M. Crane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
H. H. Wang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors
SunJa Kim et al.
JOURNAL OF NEUROCHEMISTRY (2011)
T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement
Samira Saadoun et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis
Ying Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Increased serum matrix metalloproteinase-9 in neuromyelitis optica: Implication of disruption of blood-brain barrier
Takafumi Hosokawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Simone Mader et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes
Akiko Nagaishi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
A serological analysis of viral and bacterial infections associated with neuromyelitis optica
Michiaki Koga et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
S. Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population
R. Deschamps et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Impact of rituximab on relapse rate and disability in neuromyelitis optica
Gurdesh S. Bedi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Eosinophils are required for the maintenance of plasma cells in the bone marrow
Van Trung Chu et al.
NATURE IMMUNOLOGY (2011)
Genetic analysis of aquaporin-4 in neuromyelitis optica
M. Matiello et al.
NEUROLOGY (2011)
Azathioprine Tolerability, efficacy, and predictors of benefit in neuromyelitis optica
C. Costanzi et al.
NEUROLOGY (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
H. L. Pellkofer et al.
NEUROLOGY (2011)
A population-based study of neuromyelitis optica in Caucasians
N. Asgari et al.
NEUROLOGY (2011)
Review: Water channel proteins in the human placenta and fetal membranes
A. E. Damiano
PLACENTA (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
FTY720 Regulates Bone Marrow Egress of Eosinophils and Modulates Late-Phase Skin Reaction in Mice
Kazunari Sugita et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Quantification and Functional Characterization of Antibodies to Native Aquaporin 4 in Neuromyelitis Optica
Sudhakar Reddy Kalluri et al.
ARCHIVES OF NEUROLOGY (2010)
Interferon Beta Treatment in Neuromyelitis Optica Increase in Relapses and Aquaporin 4 Antibody Titers
Jacqueline Palace et al.
ARCHIVES OF NEUROLOGY (2010)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
Samira Saadoun et al.
BRAIN (2010)
Relapsing Neuromyelitis Optica: demographic and clinical features in Iranian patients
M. A. Sahraian et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) in the Treatment of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS): A Systematic Review and Meta-Analysis
Kentaro Iwata et al.
INTERNAL MEDICINE (2010)
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
Venizelos Papayannopoulos et al.
JOURNAL OF CELL BIOLOGY (2010)
Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2010)
HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Doralina Guimaraes Brum et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius et al.
NATURE REVIEWS NEUROLOGY (2010)
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
J. Shimizu et al.
NEUROLOGY (2010)
Neuromyelitis optica and NMO-IgG in European pediatric patients
P. Huppke et al.
NEUROLOGY (2010)
Intrathecal Pathogenic Anti-Aquaporin-4 Antibodies in Early Neuromyelitis Optica
Jeffrey L. Bennett et al.
ANNALS OF NEUROLOGY (2009)
Treatment of Neuromyelitis Optica With Mycophenolate Mofetil
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2009)
Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
Saiju Jacob et al.
CURRENT NEUROPHARMACOLOGY (2009)
TNF-α and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica
Giselle Penton-Rol et al.
JOURNAL OF INFLAMMATION-LONDON (2009)
An epidemiological study of neuromyelitis optica in Cuba
Jose A. Cabrera-Gomez et al.
JOURNAL OF NEUROLOGY (2009)
Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS
Rhonda R. Voskuhl et al.
JOURNAL OF NEUROSCIENCE (2009)
Monoclonal anti body-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
Kenneth R. Carson et al.
LANCET ONCOLOGY (2009)
Complement in human diseases: Lessons from complement deficiencies
Marina Botto et al.
MOLECULAR IMMUNOLOGY (2009)
Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation
J. Fagius et al.
MULTIPLE SCLEROSIS (2009)
Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab
H. L. Pellkofer et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Is neuromyelitis optica associated with human leukocyte antigen?
H. Zephir et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
M. Bonnan et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
CD19: a promising B cell target for rheumatoid arthritis
Thomas F. Tedder
NATURE REVIEWS RHEUMATOLOGY (2009)
Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica
Arne Warth
MEDICAL HYPOTHESES (2009)
Intermittent Plasmapheresis Prevents Recurrence in Neuromyelitis Optica
Katsuichi Miyamoto et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders
T. Matsushita et al.
TISSUE ANTIGENS (2009)
Interactive Case Report A woman with acute myelopathy in pregnancy: case outcome
Reinhard Reuss et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients
Anu Jacob et al.
ARCHIVES OF NEUROLOGY (2008)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S. Jarius et al.
BRAIN (2008)
Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
Shannon R. Hinson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment
Thierry Vincent et al.
JOURNAL OF IMMUNOLOGY (2008)
Characterisation of the spectrum of demyelinating disease in Western Australia
J-S Wu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
CNS aquaporin-4 autoimmunity in children
A. McKeon et al.
NEUROLOGY (2008)
Spectrum of Pediatric Neuromyelitis Optica
Timothy E. Lotze et al.
PEDIATRICS (2008)
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
B. Banwell et al.
NEUROLOGY (2008)
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
S. R. Hinson et al.
NEUROLOGY (2007)
Complement-targeted therapeutics
Daniel Ricklin et al.
NATURE BIOTECHNOLOGY (2007)
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial
Amit Bar-Or et al.
ARCHIVES OF NEUROLOGY (2007)
Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis
S. Watanabe et al.
MULTIPLE SCLEROSIS (2007)
Idiopathic transverse myelitis - Corticosteroids, plasma exchange, or cyclophosphamide
B. M. Greenberg et al.
NEUROLOGY (2007)
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese
Takeshi Matsuoka et al.
BRAIN (2007)
A secondary progressive clinical course is uncommon in neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2007)
Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination
Yoko Warabi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica
Kazumasa Okada et al.
INTERNAL MEDICINE (2007)
Devic's neuromyelitis optica in an infant case
Deniz Yuksel et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG
I. Nakashima et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Fetal development of membrane water channel proteins aquaporin-1 and aquaporin-4 in the human brain
Eva Gomori et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2006)
Study of mitoxantrone for the treatment of recurrent neuromyelitis Optica (Devic disease)
Bianca Weinstock-Guttman et al.
ARCHIVES OF NEUROLOGY (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Corticosteroids: The drugs to beat
PJ Barnes
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Oral tolerance: Therapeutic implications for autoimmune diseases
Ana M. C. Faria et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2006)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
An open label study of the effects of rituximab in neuromyelitis optica
BAC Cree et al.
NEUROLOGY (2005)
Neutrophil elastase (NE)-deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in vivo
RE Young et al.
JOURNAL OF IMMUNOLOGY (2004)
Reactive astrocytes protect tissue and preserve function after spinal cord injury
JR Faulkner et al.
JOURNAL OF NEUROSCIENCE (2004)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Devic's neuromyelitis Optica treated with intravenous gamma globulin (IVIG)
J Bakker et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2004)
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
CF Lucchinetti et al.
BRAIN (2002)
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus
I Simon et al.
HORMONE RESEARCH (2002)
EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG
M Collin et al.
EMBO JOURNAL (2001)
MS and neuromyelitis optics in Martinique (French West Indies)
P Cabre et al.
NEUROLOGY (2001)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
B Bielekova et al.
NATURE MEDICINE (2000)
分享论文
